GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Societal CDMO Inc (FRA:RAH) » Definitions » Other Operating Expense

Societal CDMO (FRA:RAH) Other Operating Expense : €0.64 Mil (TTM As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Societal CDMO Other Operating Expense?

Societal CDMO's Other Operating Expense for the three months ended in Dec. 2023 was €0.15 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was €0.64 Mil.

Societal CDMO's quarterly Other Operating Expense increased from Jun. 2023 (€0.16 Mil) to Sep. 2023 (€0.16 Mil) but then declined from Sep. 2023 (€0.16 Mil) to Dec. 2023 (€0.15 Mil).

Societal CDMO's annual Other Operating Expense declined from Dec. 2021 (€0.92 Mil) to Dec. 2022 (€0.85 Mil) and declined from Dec. 2022 (€0.85 Mil) to Dec. 2023 (€0.63 Mil).


Societal CDMO Other Operating Expense Historical Data

The historical data trend for Societal CDMO's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Societal CDMO Other Operating Expense Chart

Societal CDMO Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.33 2.12 0.92 0.85 0.63

Societal CDMO Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.21 0.17 0.16 0.16 0.15

Societal CDMO Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.64 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Societal CDMO Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Societal CDMO's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Societal CDMO (FRA:RAH) Business Description

Traded in Other Exchanges
Address
1 E. Uwchlan Avenue, Suite 112, Exton, PA, USA, 19341
Societal CDMO Inc is a bi-coastal contract development and manufacturing organization. It offers capabilities spanning pre-Investigational New Drug development to commercial manufacturing and packaging for a wide range of therapeutic dosage forms primarily focused on small molecules. The company also provides therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging, and logistics services to the global pharmaceutical market.

Societal CDMO (FRA:RAH) Headlines

No Headlines